Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benzbromarone therapy in hyperuricaemia

W A Scott

    The Journal of International Medical Research
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Benzbromarone effectively reduced serum uric acid levels and increased urinary uric acid elimination in patients with hyperuricemia and rheumatic symptoms. Most patients experienced clinical improvement with good drug tolerance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diphtheria-Its Treatment.

    The Chicago medical journal·2023
    Same author

    Physical Education of Children.

    Hall's journal of health·2022
    Same author

    Physical Education of Children.

    Hall's journal of health·2022
    Same author

    Long-term study of litter decomposition on a Pennine peat bog: which regression?

    Oecologia·2017
    Same author

    Brief Report : Measures Of Cognitive Structure.

    Multivariate behavioral research·2016
    Same author

    Measuring stock and change in the GB countryside for policy--key findings and developments from the Countryside Survey 2007 field survey.

    Journal of environmental management·2012

    Area of Science:

    • Rheumatology
    • Pharmacology
    • Nephrology

    Background:

    • Hyperuricemia is associated with rheumatic symptoms.
    • Gout and other rheumatic conditions can be linked to high uric acid levels.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of Benzbromarone in patients with hyperuricemia and rheumatic symptoms.
    • To assess the impact of Benzbromarone on serum uric acid levels and urinary uric acid excretion.

    Main Methods:

    • A 5-month prospective study involving patients with hyperuricemia and rheumatic symptoms.
    • Clinical and biochemical assessments were conducted monthly.
    • Serum uric acid and urinary uric acid elimination rates were measured.

    Main Results:

    Related Experiment Videos

    • Benzbromarone significantly reduced serum uric acid levels in all patients.
    • Urinary uric acid elimination rates increased significantly.
    • Most patients showed clinical improvement, with good drug tolerance.
    • Two patients were withdrawn due to diarrhea and lack of efficacy.

    Conclusions:

    • Benzbromarone is an effective uricosuric agent for managing hyperuricemia associated with rheumatic symptoms.
    • The drug demonstrates good tolerability, with minor side effects observed.
    • Benzbromarone offers a viable treatment option for this patient population.